| The road to animal-free glycosaminoglycan production: current efforts and bottlenecks A Badri, A Williams, RJ Linhardt, MAG Koffas Current opinion in biotechnology 53, 85-92, 2018 | 73 | 2018 |
| Complete biosynthesis of a sulfated chondroitin in Escherichia coli A Badri, A Williams, A Awofiranye, P Datta, K Xia, W He, K Fraser, ... Nature Communications 12 (1), 1389, 2021 | 49 | 2021 |
| Metabolic engineering for production of functional polysaccharides C Schilling, A Badri, V Sieber, M Koffas, J Schmid Current Opinion in Biotechnology 66, 44-51, 2020 | 36 | 2020 |
| Increased 3′‐Phosphoadenosine‐5′‐phosphosulfate Levels in Engineered Escherichia coli Cell Lysate Facilitate the In Vitro Synthesis of Chondroitin Sulfate A A Badri, A Williams, K Xia, RJ Linhardt, MAG Koffas Biotechnology Journal 14 (9), 1800436, 2019 | 29 | 2019 |
| Uncovering Novel Pathways for Enhancing Hyaluronan Synthesis in Recombinant Lactococcus lactis: Genome-Scale Metabolic Modeling and Experimental … A Badri, K Raman, G Jayaraman Processes 7 (6), 343, 2019 | 17 | 2019 |
| Fabrication of homotypic neural ribbons as a multiplex platform optimized for spinal cord delivery ZT Olmsted, C Stigliano, A Badri, F Zhang, A Williams, MAG Koffas, Y Xie, ... Scientific Reports 10 (1), 12939, 2020 | 14 | 2020 |
| Biochemical characterization of inducible ‘Reductase’component of benzoate dioxygenase and phthalate isomer dioxygenases from Pseudomonas aeruginosa strain PP4 R Karandikar, A Badri, PS Phale Applied biochemistry and biotechnology 177, 318-333, 2015 | 8 | 2015 |
| N-glycolyl chondroitin synthesis using metabolically engineered E. coli AE Awofiranye, SN Baytas, K Xia, A Badri, W He, A Varki, M Koffas, ... AMB Express 10, 1-9, 2020 | 7 | 2020 |
| Modular optimization in metabolic engineering M Wong, A Badri, C Gasparis, G Belfort, M Koffas Critical Reviews in Biochemistry and Molecular Biology 56 (6), 587-602, 2021 | 6 | 2021 |
| In silico approaches to metabolic engineering A Badri, A Srinivasan, K Raman Current developments in biotechnology and bioengineering, 161-200, 2017 | 3 | 2017 |
| Engineering in Vivo Sulfation in Escherichia Coli for the Complete Biosynthesis of Sulfated Glycosaminoglycans A Badri Rensselaer Polytechnic Institute, 2020 | 1 | 2020 |
| Recombinant microorganisms for in vivo production of sulfated glycosaminoglycans A Badri, MAG KOFFAS, RJ Linhardt, AJ Williams US Patent App. 17/641,675, 2022 | | 2022 |
| Microbial Synthesis of Chondroitin Sulfates and N-Glycolyl Chondroitin Using Engineered Escherichia coli. A Awofiranye, A Badri, AJ Williams, K Xia, P Datta, K Fraser, W He, ... 2021 AIChE Annual Meeting, 2021 | | 2021 |
| Outside Back Cover: Biotechnology Journal 9/2019 A Badri, A Williams, K Xia, RJ Linhardt, MAG Koffas Biotechnology Journal 14 (9), 1970095, 2019 | | 2019 |
| Engineering sulfate donor accumulation in Escherichia coli: Improved in vitro chondroitin sulfate biotransformation and a step towards in vivo microbial production A Badri, R Linhardt, M Koffas ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 257, 2019 | | 2019 |
| Engineering sulfate donor accumulation in Escherichia coli for synthesis of sulfated glycosaminoglycans A Badri, A Williams, R Linhardt, M Koffas, K Xia | | 2019 |
Mattheos KoffasProfessor of Chemical and Biological Engineering and Professor of BiologyVerified email at rpi.edu
